Treatment of heparin-induced thrombocytopenia with fondaparinux
Anticoagulation of patients with heparin-induced thrombocytopenia (HIT) may be limited by cross-reaction of HIT antibodies with danaparoid and generation of antibodies during therapy with lepirudin. We used fondaparinux to treat 6 patients with a history of HIT with thromboembolism and 2 patients wi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
2004
|
| In: |
Haematologica
Year: 2004, Volume: 89, Issue: 8, Pages: 1017-1018 |
| ISSN: | 1592-8721 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://haematologica.org/article/view/3180
|
| Author Notes: | J. Harenberg, I. Jorg, T. Fenyvesi |
| Summary: | Anticoagulation of patients with heparin-induced thrombocytopenia (HIT) may be limited by cross-reaction of HIT antibodies with danaparoid and generation of antibodies during therapy with lepirudin. We used fondaparinux to treat 6 patients with a history of HIT with thromboembolism and 2 patients with thrombocytopenia during low-molecular-weight heparin administration. |
|---|---|
| Item Description: | Gesehen am 21.04.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1592-8721 |